Your browser doesn't support javascript.
loading
Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
Sakkat, Abdullah; Cox, Gerard; Khalidi, Nader; Larche, Maggie; Beattie, Karen; Renzoni, Elisabetta A; Morar, Nilesh; Kouranos, Vasilis; Kolb, Martin; Hambly, Nathan.
Afiliação
  • Sakkat A; Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia. asakkat@kau.edu.sa.
  • Cox G; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Khalidi N; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.
  • Larche M; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Beattie K; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada.
  • Renzoni EA; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Morar N; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada.
  • Kouranos V; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Kolb M; Division of Rheumatology, McMaster University, Hamilton, Ontario, Canada.
  • Hambly N; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK.
Respir Res ; 23(1): 54, 2022 Mar 09.
Article em En | MEDLINE | ID: mdl-35264154
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoidose / Resistência a Medicamentos / Prednisona / Infliximab Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoidose / Resistência a Medicamentos / Prednisona / Infliximab Idioma: En Ano de publicação: 2022 Tipo de documento: Article